TY - JOUR T1 - Exponential damping key to successful containment of COVID-19 outbreak JF - medRxiv DO - 10.1101/2020.03.22.20041111 SP - 2020.03.22.20041111 AU - Feng Zhang AU - Jinmei Zhang AU - Menglan Cao AU - Yong Zhang AU - Cang Hui Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/03/27/2020.03.22.20041111.abstract N2 - Due to the excessively high capability of human-to-human transmission, the 2019 novel coronavirus disease (COVID-19), first reported in Wuhan of China, has rapidly spread to the entire nation and beyond, and has now been declared a global public health emergency. Understanding the transmission pattern of the virus and the effect of control measures on the transmission, is crucial to improving the national and international disease control effectiveness. We here propose a simple model based on the exponential infectious growth but with a time-varying, largely damping, transmission rate. This model provides an excellent fit to the existing data and, we think, has largely captured the transmission pattern of the COVID-19 outbreak under a variety of intervention and control measures. Successful control measures, such as in China and South Korea, have resulted in an exponentially damping dynamics of the viral spread. Such exponential damping, therefore, could be used as a measure of control effectiveness, as also shown in the data of the 2003 severe acute respiratory syndrome (SARS). Our model suggests that the COVID-19 outbreak is currently accelerating worldwide with the exponential damping yet to emerge. Consistent with the message from the World Health Organisation (WHO), we thus strongly suggest all countries to take active measures to contain this global pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFZ is supported by the National Natural Science Foundation of China (No. 31360104) and AHU (No. S020118002/101); CH is supported by the National Research Foundation of South Africa (grant 89967).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data can be obtained from the website of NHCC and WHO. ER -